Skip to main content
DataroomDataroom
Data room
  • Welcome to Legit.Health's Data Room
  • Bridge Round
  • Pitch deck
  • Cap Table
  • Product
  • Sales
  • Financials
    • ARR & Revenue Mix
    • Balance Sheet
    • Funding
    • Cash flow
    • Key Financials
    • Profit and Loss
  • Regulatory
  • Team
  • Trajectory & Recognition
  • Financials
  • Balance Sheet

Balance Sheet

2025 (formulated 4 May 2026)​

Board-formulated annual accounts

The 2025 annual accounts were formulated by the Board on 4 May 2026 (Art. 253 LSC) in abbreviated format, comprising abbreviated Balance Sheet, abbreviated Profit and Loss Statement, and Notes to the Financial Statements (Memoria). Filed with auditor's report pending issuance.

Headline figures (31 December 2025)​

Magnitude20252024
Total assets€5.67M€5.63M
Equity€4.41M€5.13M
Intangible assets€3.19M€2.75M
Capitalised CDTI grants (within equity)€2.28M€2.48M

Allocation of the 2025 result​

The Board unanimously resolved on 4 May 2026 to apply the −€517,357 loss of the financial year against prior-year results (account 121 — Resultados negativos de ejercicios anteriores).

2024​

Final audited accounts available upon request.

Auditor​

The 2025 annual accounts are subject to audit. The auditor's report is scheduled for issuance after formulation.

Previous
ARR & Revenue Mix
Next
Funding
  • 2025 (formulated 4 May 2026)
    • Headline figures (31 December 2025)
    • Allocation of the 2025 result
  • 2024
  • Auditor
All the information contained in this data room is confidential. The recipient agrees not to transmit or reproduce the information, neither by himself nor by third parties, through whichever means, without obtaining the prior written permission of Legit.Health (AI Labs Group S.L.)